STUDY: IMMUNOTHERAPY BETTER THAN CHEMOTHERAPY FOR SUBTYPE OF HEAD AND NECK CANCER

Pers / media: Vakinhoudelijk commentaar

Periode30 nov 2018

Media-aandacht

1

Media-aandacht

  • TitelSTUDY: IMMUNOTHERAPY BETTER THAN CHEMOTHERAPY FOR SUBTYPE OF HEAD AND NECK CANCER
    Media naam/outletStates News Service
    LandVerenigde Staten van Amerika
    Release datum30/11/18
    PersonenJonathan S. Cheng